SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Neuralstem Inc. (CUR)

CUR RSS Feed
Add CUR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/26/2017 10:11:04 AM - Followers: 177 - Board type: Free - Posts Today: 0

 

Neuralstem Inc. (CUR)

 

 

http://www.neuralstem.com/

 

 

 

Company Information:

Neuralstem, Inc.
9700 Great Seneca Highway
Suite 240
Rockville, MD 20850

301-366-4841

 

CIK:  0001357459

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of central nervous system therapies based on its proprietary human neuronal stem cells and stem-cell derived small molecule compounds. The company?s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical development products include NSI-189, which has completed Phase I clinical trial for the treatment of major depressive disorder, as well as is in Phase I clinical trial for the treatment of other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy; and NSI?566 that has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as is in Phase I clinical trials for the treatment of chronic spinal cord injury and motor deficits due to ischemic stroke. The company was founded in 1996 and is headquartered in Germantown, Maryland.

 

 NeuralStem Inc. Announces First Patient Enrolled In Phase 2 Clinical Trial In Major Depressive Disorder
http://www.biospace.com/News/neuralstem-inc-announces-first-patient-enrolled-in/419306

To follow the  Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder

Link here;
https://clinicaltrials.gov/ct2/show/NCT02695472?term=nsi-189&rank=1

 

Management: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-govmanage

 

 

 

 

 

 

 

INTELLECTUAL PROPERTY

At the heart of  Neuralstem's therapeutic cell development programs is the is ability to isolate and grow human neural stem cells from diverse regions of the developing human brain and spinal cord.
 
This technology is supported by our portfolio of issued and pending patents.  The Company has a very pro active plan for obtaining and protecting it's stem cell Intellectual Property, not just in the United States, but world wide.  In addition to it's stem cell intellectual property, the company has been active in licensing in important intellectual property rights for newly developed devices and equipment that will be required to optimize delivery of  it's stem cell therapeutics through surgical transplantation into the brain and spinal cord.

 

Patents Issued

 Number

Country  

 Filing Date

 Issue Date

 Expiration Date

 Title 

 5,753,506

 US

 09/25/96

 05/19/98

 09/25/2016

Isolation, Propagation, and Directed Differentiation of Stem Cell from Embryonic and Adult Central Nervous System of Mammals 

 6,040,180

 US

 05/07/97

 03/21/00

 09/25/2016

In Vitro Generation of Differentiated Neurons from Cultures of Mammalian Multi-potential CNS Stem Cell

 6,284,539

 US 

 10/09/98

 09/04/01

 10/9/2018

Method for Generating Dopaminergic Cells Derived from Neural Precursors

 755849 

 Australia

 09/22/99 

 04/03/03

 09/20/2019

Stable Neural Stem Cell Lines


Investor Information:
http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-IRHome

Recent News: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-news&nyo=0

 

http://finance.yahoo.com/q/h?s=CUR+Headlines

 

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357459&type=&dateb=&owner=include&count=40

 

Transfer Agent:

American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038

 

Share Structure:

See filings

Common Stock

Authorized 300,000,000 6/30/16
Issued and Outstanding 2016 114,760,960 7/31/16
Issued and Outstanding 2015 92,005,705 6/30/16


Prefered Stock

Authorized 7,000,000 6/30/16
Issued 0 6/30/16
Outstanding 0 6/30/16


 


 

Investor Relations:

Neuralstem, Inc. 
Phone: 301-366-4960 x1
E-mail:
investor@neuralstem.com

 

 

 

 

 

 



 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

 

Please keep your posts on topic because your message(s) will probably be deleted when:

* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

CUR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#4455   YAY Seminole Red 06/26/17 10:11:04 AM
#4454   Interesting... Cbdpotential 06/26/17 09:08:55 AM
#4453   Neuralstem Added to the Russell Microcap Index crowin 06/26/17 08:34:05 AM
#4452   yay Seminole Red 06/23/17 03:32:52 PM
#4451   CUR just hit a new 13 week high crowin 06/23/17 01:21:40 PM
#4450   go baby go Seminole Red 06/22/17 12:07:04 PM
#4449   Had some of this @ 4.16 p/s Bearly Bullish 05/18/17 11:35:07 PM
#4448   Neuralstem Reports Last Subject Out in Phase 2 crowin 05/18/17 07:33:56 AM
#4447   Large fall yesterday gilotron 05/09/17 05:12:10 AM
#4446   nsi-189 patent gilotron 04/30/17 08:29:52 AM
#4445   https://clinicaltrials.gov/ct2/show/NCT01772810 crowin 04/12/17 07:44:07 AM
#4443   Finally.... they ER !!! 08190819 03/23/17 07:51:07 AM
#4442   Now in the news says on 27th.... I 08190819 03/22/17 07:24:15 PM
#4441   Where is that info from? Still no ER out. s_Henderson 03/22/17 03:36:15 PM
#4440   Neuralstem, Inc. (CUR) Upcoming Earnings fourth-quarter earnings release 08190819 03/15/17 06:44:02 PM
#4439   Today I double my money in 2 month 08190819 03/15/17 02:55:25 PM
#4438   Should be getting close to even this week wiredawg 03/15/17 12:17:27 PM
#4437   Since that R/S still underwater. mokew 03/14/17 02:31:25 PM
#4436   CUR = steady rise $5.98 crowin 03/14/17 01:44:16 PM
#4435   CUR kikin az again today crowin 03/10/17 11:23:53 AM
#4434   I got CURed at 3.83 2 months ago. crowin 03/09/17 05:19:03 PM
#4433   WOW NOT MANY EVEN POSTING HERE [SMART MONEY] 03/09/17 04:59:49 PM
#4432   Neuralstem Announces Publication of NSI-566 Data in a crowin 03/09/17 12:49:35 PM
#4431   Neuralstem, Inc. (NASDAQ:CUR) Is Up. Here’s Why And trendmkr 02/17/17 03:34:26 PM
#4430   God this stock is such a POS shanghai_steve 02/17/17 10:22:50 AM
#4429   * * $CUR Video Chart 02-16-17 * * ClayTrader 02/16/17 05:19:04 PM
#4428   go CUR! http://finance.yahoo.com/news/neuralstem-announces-last-subject-enroll TheHound 02/16/17 12:08:28 PM
#4427   Neuralstem, Inc. is estimated to report earnings on 08190819 02/06/17 03:54:07 PM
#4426   I understand you 100% and it takes guts raja48185 02/04/17 03:30:46 PM
#4425   What happened today. Up 12 cents,,can't be right moneymaker290 02/03/17 06:41:45 PM
#4424   Continuing on the reverse split downward trend. CUIN2 02/02/17 05:19:46 PM
#4423   Same as me... Lets see if they 08190819 01/31/17 10:06:10 PM
#4422   If $CUR has something going on I will TheRealMrPirate 01/31/17 10:14:18 AM
#4421   Why they did R/S from .31 to 4 08190819 01/31/17 09:59:14 AM
#4420   Huge pos with nothing positive to show. shanghai_steve 01/31/17 09:36:02 AM
#4419   $CUR was already in Nasdaq suspension. I held TheRealMrPirate 01/31/17 07:43:45 AM
#4417   i understand why they did what they did. TheHound 01/30/17 04:29:05 PM
#4416   CUR is an excellent example of why non-rev s_Henderson 01/30/17 04:20:55 PM
#4415   Yep CUIN2 01/30/17 01:19:13 PM
#4414   CUR is an excellent example of why non-rev TheHound 01/30/17 11:35:56 AM
#4413   I agree, CUR is cheap at this current crowin 01/29/17 08:02:15 PM
#4412   RS is gonna kill investors here. SurgicalTechnologist 01/29/17 06:15:12 PM
#4411   You don't have to state the very obvious s_Henderson 01/29/17 05:48:11 PM
#4409   Something is coming up soon... orrrr this CEO 08190819 01/29/17 02:01:13 AM
#4408   CUR waiting on FDA approval is just a crowin 01/28/17 08:06:12 PM
#4407   More Insider Buying: s_Henderson 01/28/17 09:20:17 AM
#4406   At 0.31 CUR was out of Nasdaq, thats 08190819 01/27/17 04:40:57 PM
#4405   R/S = Death By A Thousand Paper Cuts. CUIN2 01/26/17 04:00:33 PM
#4404   And another 5% today, it will be back mokew 01/26/17 02:41:10 PM
#4403   12% loss so far (if you held through CUIN2 01/25/17 10:55:23 PM
PostSubject